Trimipramine

{{DrugProjectFormSinglePage |authorTag=Pratik Bahekar, MBBS [1] |genericName=Trimipramine |aOrAn=a |drugClass=Tricyclic antidepressant |indication=depression |hasBlackBoxWarning=Yes |adverseReactions=hypotension, tachycardia, constipation, xerostomia, dizziness, somnolence, blurred vision |blackBoxWarningTitle=TITLE |blackBoxWarningBody=Condition Name: (Content)

|fdaLIADAdult=

Depression

• 75 mg PO (divided into 1-3 doses per day), increase gradually to 150 mg/day to maximum 200 mg/day for outpatient treatment. Maintenance 50-150 mg/day PO, bedtime, for 3 months.
• 100 mg PO (divided into 1-3 doses per day), increase gradually to 200 mg/day, if unsatisfactory response in in 2-3 weeks, increase to a maximum 300 mg/day for inpatient treatment.

|offLabelAdultGuideSupport=Condition 1

• Developed by: (Organization)

• Class of Recommendation: (Class) (Link)

• Strength of Evidence: (Category A/B/C) (Link)

• Dosing Information/Recommendation

• (Dosage)

|offLabelAdultNoGuideSupport=:* There is limited information about Off-Label Non–Guideline-Supported Use of Trimipramine in adult patients.

|fdaLIADPed=

Depression

• FDA approved for adolescents, and not for children.
• 50 mg/day PO may increase up to 100 mg/day for adolescents;

|offLabelPedGuideSupport=Condition 1

• Developed by: (Organization)

• Class of Recommendation: (Class) (Link)

• Strength of Evidence: (Category A/B/C) (Link)

• Dosing Information/Recommendation

• (Dosage)

|offLabelPedNoGuideSupport=:* There is limited information about Off-Label Non–Guideline-Supported Use of Trimipramine in pediatric patients. |contraindications=* Condition 1

• Condition 2
• Condition 3
• Condition 4
• Condition 5

|warnings=Conidition 1

(Description) |clinicalTrials=Central Nervous System

(list/description of adverse reactions)

Cardiovascular

(list/description of adverse reactions)

Respiratory

(list/description of adverse reactions)

Gastrointestinal

(list/description of adverse reactions)

Hypersensitive Reactions

(list/description of adverse reactions)

Miscellaneous

(list/description of adverse reactions)

|postmarketing=Central Nervous System

(list/description of adverse reactions)

Cardiovascular

(list/description of adverse reactions)

Respiratory

(list/description of adverse reactions)

Gastrointestinal

(list/description of adverse reactions)

Hypersensitive Reactions

(list/description of adverse reactions)

Miscellaneous

(list/description of adverse reactions)

|drugInteractions=* (Drug 1)

• (Description)

• (Drug 2)

• (Description)

• (Drug 3)

• (Description)

|fdaPatientInfo=For patient information about Trimipramine from NLM, click [[Trimipramine (patient information) |alcohol=Alcohol-Trimipramine interaction has not been established. Talk to your doctor about the effects of taking alcohol with this medication. }}